Associate Professor Andrew Cox is a group leader in the Organogenesis and Cancer Program at the Peter MacCallum Cancer Centre and holds a joint appointment in the Department of Biochemistry and Pharmacology at the University of Melbourne.

In 2009, Andrew received his PhD from the University of Otago, New Zealand. He then undertook postdoctoral training with Profressor Wolfram Goessling at Brigham and Women’s Hospital, Harvard Medical School. During this time, he developed zebrafish models of liver regeneration and liver cancer (Cell Reports 2014 and PNAS 2016). These studies led to discovery that the Hippo pathway reprograms metabolism to fuel oncogenic growth (Nature Cell Biology 2016).

In 2016, Andrew was recruited to the Peter MacCallum Cancer Centre to establish his laboratory. His research team use zebrafish as a model system to understand the metabolic regulation of growth control in the context of development, regeneration and cancer (EMBO J 2018, Developmental Cell 2022, PNAS 2023, Developmental Cell 2024).

Andrew has been the recipient of fellowships from the American Liver Foundation, the NHMRC and the Victorian Cancer Agency.